We compared our findings of CCNE1 amplification rates in EGC with the Memorial Sloan Kettering (MSK) Cancer Discovery 2017 cohort (26) [publicly available in cBioPortal (27, 28)] (Supplementary Fig. S4A). The gene discussed is CCNE1; the disease is cancer.